Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

LH – Laboratory Corporation of America Holdings

LH — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

3.86

Margin Of Safety %

12

Put/Call OI Ratio

0.65

EPS Next Q Diff

0.34

EPS Last/This Y

7.46

EPS This/Next Y

1.44

Price

259.93

Target Price

311.19

Analyst Recom

1.52

Performance Q

-8.84

Upside

-4.5%

Beta

0.9

Ticker: LH




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23LH2651.950.459536
2026-04-24LH263.82.230.009374
2026-04-27LH263.382.2320.009378
2026-04-28LH259.612.254.179418
2026-04-29LH257.432.251.539444
2026-04-30LH256.992.010.1411304
2026-05-01LH255.971.970.4311406
2026-05-04LH253.061.960.1111442
2026-05-05LH257.112.030.7611461
2026-05-06LH256.952.0044.6211581
2026-05-07LH258.031.168.178939
2026-05-08LH254.131.185.889024
2026-05-11LH255.111.190.369048
2026-05-12LH257.421.181.009081
2026-05-13LH254.381.180.579076
2026-05-14LH254.031.180.539084
2026-05-15LH250.381.104.719076
2026-05-18LH255.610.660.111763
2026-05-19LH253.580.620.251843
2026-05-20LH257.360.620.501851
2026-05-21LH255.770.629.801871
2026-05-22LH259.940.650.451923
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23LH264.997.271.617.79
2026-04-24LH263.747.298.317.79
2026-04-27LH263.387.2101.517.79
2026-04-28LH259.647.287.117.79
2026-04-30LH256.867.2102.117.79
2026-05-01LH255.917.284.117.79
2026-05-04LH253.007.291.117.98
2026-05-05LH257.2010.0121.617.99
2026-05-06LH256.9110.0102.117.99
2026-05-07LH258.0410.046.618.00
2026-05-08LH254.0710.042.718.00
2026-05-11LH255.1910.064.418.00
2026-05-12LH257.2310.069.118.00
2026-05-13LH254.4010.047.118.00
2026-05-14LH253.9510.057.718.00
2026-05-15LH250.3710.043.918.00
2026-05-18LH255.5110.082.218.00
2026-05-19LH253.5910.051.418.00
2026-05-20LH257.2410.075.218.00
2026-05-21LH255.6710.052.218.00
2026-05-22LH259.9310.077.818.00
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23LH-8.512.203.89
2026-04-24LH-8.512.203.89
2026-04-27LH-8.53-0.223.96
2026-04-28LH-8.53-0.223.96
2026-04-29LH-8.53-0.223.96
2026-04-30LH-8.53-0.223.96
2026-05-01LH-8.53-0.223.96
2026-05-04LH-8.53-0.103.96
2026-05-05LH-6.65-0.103.96
2026-05-06LH-6.65-0.103.96
2026-05-07LH-6.66-0.103.96
2026-05-08LH-6.66-0.103.96
2026-05-11LH-6.660.063.96
2026-05-12LH-6.660.063.87
2026-05-13LH-6.700.063.87
2026-05-14LH-6.700.063.87
2026-05-15LH-6.700.063.87
2026-05-18LH-6.701.903.87
2026-05-19LH-6.851.903.87
2026-05-20LH-6.851.903.87
2026-05-21LH-6.851.903.86
2026-05-22LH-7.171.903.86
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

4.25

Avg. EPS Est. Current Quarter

4.78

Avg. EPS Est. Next Quarter

4.59

Insider Transactions

-7.17

Institutional Transactions

1.9

Beta

0.9

Average Sales Estimate Current Quarter

3711

Average Sales Estimate Next Quarter

3751

Fair Value

291.16

Quality Score

70

Growth Score

71

Sentiment Score

94

Actual DrawDown %

11.5

Max Drawdown 5-Year %

-34.5

Target Price

311.19

P/E

23.05

Forward P/E

13.34

PEG

1.51

P/S

1.51

P/B

2.45

P/Free Cash Flow

15.41

EPS

11.29

Average EPS Est. Cur. Y​

18

EPS Next Y. (Est.)

19.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.66

Relative Volume

0.88

Return on Equity vs Sector %

-16.3

Return on Equity vs Industry %

-0.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.22

EBIT Estimation

77.8
LH Healthcare
$260.09
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
15/25
Volume
7/15
Valuation
16/20
TP/AR
1/10
Options
5/10
RSI
51.6
Range 1M
46%
Sup Dist
3.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
29 /100
WEAK
Momentum
1/25
Growth
13/30
Estimates
4/20
Inst/Vol
4/15
Options
7/10
EPS Yr
9.6%
EPS NY
8.2%
52W%
38.2%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +39.7% upside
Quality
7/30
Valuation
13/30
Growth
8/25
Stability
6/10
LT Trend
0/5
Upside
+39.7%
Quality
70
MoS
12%
Labcorp Holdings Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 71000
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI-enabled Test Selection, a generative AI-enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. The company has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
LH

Latest News

Caricamento notizie per LH
stock quote shares LH – Laboratory Corporation of America Holdings Stock Price stock today
news today LH – Laboratory Corporation of America Holdings stock forecast ,stock prediction 2023 2024 2025
marketwatch LH – Laboratory Corporation of America Holdings yahoo finance google finance
stock history LH – Laboratory Corporation of America Holdings invest stock market
stock prices LH premarket after hours
ticker LH fair value insiders trading